Skip to main content

Advertisement

Log in

Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Low vitamin D status has been associated with cardiovascular disease (CVD) and mortality primarily in selected groups, smaller studies, or with self-reported vitamin D intake. We investigated the association of serum vitamin D status with the incidence of a registry-based diagnosis of ischemic heart disease (IHD), stroke, and all-cause mortality in a large sample of the general population. A total of 9,146 individuals from the two population-based studies, Monica10 and Inter99, were included. Measurements of serum 25-hydroxyvitamin D at baseline were carried out using the IDS ISYS immunoassay system in Monica10 and High-performance liquid chromatography in Inter99. Information on CVDs and causes of death was obtained from Danish registries until 31 December 2008. There were 478 cases of IHD, 316 cases of stroke, and 633 deaths during follow-up (mean follow-up 10 years). Cox regression analyses with age as underlying time axis showed a significant association between vitamin D status and all-cause mortality with a HR = 0.95 (P = 0.005) per 10 nmol/l higher vitamin D level. We found no association between vitamin D status and incidence of IHD or stroke (HR = 1.01, P = 0.442 and HR = 1.00, P = 0.920, respectively). In this large general population study, the observed inverse association between serum vitamin D status and all-cause mortality was not explained by a similar inverse association with IHD or stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007)

    Article  PubMed  CAS  Google Scholar 

  2. P. Autier, S. Gandini, Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167, 1730–1737 (2007)

    Article  PubMed  CAS  Google Scholar 

  3. N. Vilarrasa, J. Vendrell, J. Maravall, I. Elio, E. Solano, J.P. San, I. Garcia, N. Virgili, J. Soler, J.M. Gomez, Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38, 235–242 (2010)

    Article  PubMed  CAS  Google Scholar 

  4. M. Rotondi, L. Chiovato, Vitamin D deficiency in patients with Graves’ disease: probably something more than a casual association. Endocrine (2012). doi:10.1007/s12020-012-9776-y

  5. Y.C. Li, G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, J. Kong, Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89–90, 387–392 (2004)

    Article  PubMed  Google Scholar 

  6. J.H. Lee, J.H. O’Keefe, D. Bell, D.D. Hensrud, M.F. Holick, Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 52, 1949–1956 (2008)

    Article  PubMed  CAS  Google Scholar 

  7. M. Ohsawa, T. Koyama, K. Yamamoto, S. Hirosawa, S. Kamei, R. Kamiyama, 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 102, 2867–2872 (2000)

    Article  PubMed  CAS  Google Scholar 

  8. K. Muller, P.M. Haahr, M. Diamant, K. Rieneck, A. Kharazmi, K. Bendtzen, 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506–512 (1992)

    Article  PubMed  CAS  Google Scholar 

  9. K.C. Chiu, A. Chu, V.L. Go, M.F. Saad, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79, 820–825 (2004)

    PubMed  CAS  Google Scholar 

  10. N.C. Bozkurt, E. Cakal, M. Sahin, E.C. Ozkaya, H. Firat, T. Delibasi, The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41, 518–525 (2012)

    Article  PubMed  CAS  Google Scholar 

  11. A.D. Lopez, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J. Murray, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747–1757 (2006)

    Article  PubMed  Google Scholar 

  12. S. Jaimungal, K. Wehmeier, A.D. Mooradian, M.J. Haas, The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis. Nutr. Res. 31, 805–812 (2011)

    Article  PubMed  CAS  Google Scholar 

  13. A.S. Kim, S.C. Johnston, Global variation in the relative burden of stroke and ischemic heart disease. Circulation 124, 314–323 (2011)

    Article  PubMed  Google Scholar 

  14. J. Kendrick, G. Targher, G. Smits, M. Chonchol, 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205, 255–260 (2009)

    Article  PubMed  CAS  Google Scholar 

  15. E.S. Ford, G. Zhao, J. Tsai, C. Li, Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study. Int. J. Epidemiol. 40, 998–1005 (2011)

    Article  PubMed  Google Scholar 

  16. S. Pilz, H. Dobnig, G. Nijpels, R.J. Heine, C.D. Stehouwer, M.B. Snijder, R.M. van Dam, J.M. Dekker, Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxf) 71, 666–672 (2009)

    Article  CAS  Google Scholar 

  17. A. Kilkkinen, P. Knekt, A. Aro, H. Rissanen, J. Marniemi, M. Heliovaara, O. Impivaara, A. Reunanen, Vitamin D status and the risk of cardiovascular disease death. Am. J. Epidemiol. 170, 1032–1039 (2009)

    Article  PubMed  Google Scholar 

  18. W. Messenger, C.M. Nielson, H. Li, T. Beer, E. Barrett-Connor, K. Stone, J. Shannon, Serum and dietary vitamin D and cardiovascular disease risk in elderly men: A prospective cohort study. Nutr. Metab. Cardiovasc. Dis. 22, 856–863 (2011)

    Article  PubMed  Google Scholar 

  19. M.L. Melamed, E.D. Michos, W. Post, B. Astor, 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629–1637 (2008)

    Article  PubMed  Google Scholar 

  20. N.C. Grandi, L.P. Breitling, H. Brenner, Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev. Med. 51, 228–233 (2010)

    Article  PubMed  CAS  Google Scholar 

  21. L. Wang, J.E. Manson, Y. Song, H.D. Sesso, Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152, 315–323 (2010)

    Article  PubMed  Google Scholar 

  22. A.G. Pittas, M. Chung, T. Trikalinos, J. Mitri, M. Brendel, K. Patel, A.H. Lichtenstein, J. Lau, E.M. Balk, Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307–314 (2010)

    Article  PubMed  Google Scholar 

  23. D.P. Trivedi, R. Doll, K.T. Khaw, Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469 (2003)

    Article  PubMed  CAS  Google Scholar 

  24. M.B. Elamin, N.O. Abu Elnour, K.B. Elamin, M.M. Fatourechi, A.A. Alkatib, J.P. Almandoz, H. Liu, M.A. Lane, R.J. Mullan, A. Hazem, P.J. Erwin, D.D. Hensrud, M.H. Murad, V.M. Montori, Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96, 1931–1942 (2011)

    Article  PubMed  CAS  Google Scholar 

  25. M.H. Olsen, T.W. Hansen, M.K. Christensen, F. Gustafsson, S. Rasmussen, K. Wachtell, H. Ibsen, C. Torp-Pedersen, P.R. Hildebrandt, N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur. Heart J. 28, 1374–1381 (2007)

    Article  PubMed  CAS  Google Scholar 

  26. T. Jorgensen, K. Borch-Johnsen, T.F. Thomsen, H. Ibsen, C. Glumer, C. Pisinger, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10, 377–386 (2003)

    Article  PubMed  Google Scholar 

  27. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech. Rep. Ser. 894, i-253 (2000)

  28. G.D. Carter, R. Carter, J. Jones, J. Berry, How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin. Chem. 50, 2195–2197 (2004)

    Article  PubMed  CAS  Google Scholar 

  29. B. Thuesen, L. Husemoen, M. Fenger, J. Jakobsen, P. Schwarz, U. Toft, L. Ovesen, T. Jorgensen, A. Linneberg, Determinants of vitamin D status in a general population of Danish adults. Bone 50, 605–610 (2012)

    Article  PubMed  CAS  Google Scholar 

  30. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen, The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan. Med. Bull. 46, 263–268 (1999)

    PubMed  CAS  Google Scholar 

  31. K. Juel, K. Helweg-Larsen, The Danish registers of causes of death. Dan. Med. Bull. 46, 354–357 (1999)

    PubMed  CAS  Google Scholar 

  32. J.L. Anderson, H.T. May, B.D. Horne, T.L. Bair, N.L. Hall, J.F. Carlquist, D.L. Lappe, J.B. Muhlestein, Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106, 963–968 (2010)

    Article  PubMed  CAS  Google Scholar 

  33. A.A. Ginde, R. Scragg, R.S. Schwartz, C.A. Camargo Jr, Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 57, 1595–1603 (2009)

    Article  PubMed  Google Scholar 

  34. M.S. Hutchinson, G. Grimnes, R.M. Joakimsen, Y. Figenschau, R. Jorde, Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur. J. Endocrinol. 162, 935–942 (2010)

    Article  PubMed  CAS  Google Scholar 

  35. R.D. Semba, D.K. Houston, S. Bandinelli, K. Sun, A. Cherubini, A.R. Cappola, J.M. Guralnik, L. Ferrucci, Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64, 203–209 (2010)

    Article  PubMed  CAS  Google Scholar 

  36. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, K. Lanier, E.J. Benjamin, R.B. D’Agostino, M. Wolf, R.S. Vasan, Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503–511 (2008)

    Article  PubMed  CAS  Google Scholar 

  37. F. Hosseinpanah, M. Yarjanli, F. Sheikholeslami, M. Heibatollahi, P.S. Eskandary, F. Azizi, Associations between vitamin D and cardiovascular outcomes: Tehran Lipid and Glucose Study. Atherosclerosis 218, 238–242 (2011)

    Article  PubMed  CAS  Google Scholar 

  38. J. Hsia, G. Heiss, H. Ren, M. Allison, N.C. Dolan, P. Greenland, S.R. Heckbert, K.C. Johnson, J.E. Manson, S. Sidney, M. Trevisan, Calcium/vitamin D supplementation and cardiovascular events. Circulation 115, 846–854 (2007)

    Article  PubMed  CAS  Google Scholar 

  39. J.P. Wielders, F.A. Wijnberg, Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin. Chem. 55, 1584–1585 (2009)

    Article  PubMed  CAS  Google Scholar 

  40. W.B. Grant, Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinology 3, 199–204 (2011)

    CAS  Google Scholar 

  41. R. Jorde, M. Sneve, M. Hutchinson, N. Emaus, Y. Figenschau, G. Grimnes, Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am. J. Epidemiol. 171, 903–908 (2010)

    Article  PubMed  Google Scholar 

  42. G. Snellman, H. Melhus, R. Gedeborg, L. Byberg, L. Berglund, L. Wernroth, K. Michaelsson, Determining vitamin D status: a comparison between commercially available assays. PLoS ONE 5, e11555 (2010)

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Rikke Kart Jacobsen for statistical support and the participants and all members of the Inter99 staff at Research Centre for Prevention and Health. The Inter99 study was initiated by Torben Jørgensen, DMSci (principal investigator); Knut Borch-Johnsen, DMSci, (co-principal investigator); Troels Thomsen, PhD; and Hans Ibsen, DMSci. The Steering Committee comprises the former two and Charlotta Pisinger, PhD, MPH. We would like to thank IDS Nordic a/s for performing vitamin D measurements in the Monica10 study. The present study was supported by The Health Insurance Foundation (Grant Number 2010 B 131).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

Participants gave their informed consent in both studies, and the studies were approved by the local Ethics Committees and the Danish Data Protection Agency. The recommendations of the Declaration of Helsinki were followed.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tea Skaaby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skaaby, T., Husemoen, L.L.N., Pisinger, C. et al. Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43, 618–625 (2013). https://doi.org/10.1007/s12020-012-9805-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-012-9805-x

Keywords

Navigation